合物多尿素纳米囊与白蛋白的立体选择性相互作用
Amani Zoabi1, Adan Sultan1, Malak Abo Alhija1
1The Institute for Drug Research, the School of Pharmacy, the Faculty of Medicine, The Center for Nanoscience and Nanotechnology, The Hebrew University of Jerusalem, Jerusalem 9112192, Israel.
ACS applied materials & interfaces
|August 23, 2024
概括
基拉尔纳米囊与白蛋白蛋白具有明显的相互作用,影响它们的生物行为. 这种依赖于度的相互作用影响细胞吸收,并为向药物递送系统提供了潜在的潜力.
科学领域:
- 纳米技术 纳米技术
- 生物材料科学 生物材料科学
- 立体化学是一种立体化学.
背景情况:
- 纳米结构中的性越来越被认为具有调节生物相互作用的潜力.
- 了解立体选择性相互作用对于开发用于生物医学应用的先进纳米材料至关重要.
研究的目的:
- 为了研究合性多尿素纳米囊与专素的立体选择性相互作用.
- 探索纳米囊表面成分对这些相互作用和潜在的药物输送应用的影响.
- 评估性对细胞内化和生物兼容性的影响.
主要方法:
- 使用d-或l-lysine反体对二烯2,4-二异酸盐进行界面聚合,合成奇拉性多尿素纳米囊.
- 使用电子显微镜和原子力显微镜对纳米囊大小,形态和表面特性进行表征.
- 通过尺寸变化,光火和表面电荷测量评估白蛋白吸附;生物相容性和细胞吸收的评估.
主要成果:
- 基拉尔多尿素纳米囊表现出显著的立体选择性相互作用与白蛋白,独立于表面潜力.
- D-纳米囊显示了比l-纳米囊更多的2.1到2.6倍的专素吸附,这与形态差异 (形,更粗的表面) 有关.
- 通过调整单体比率来调整胺吸附;d-纳米囊显示细胞内化增加2.5倍.
结论:
- 状纳米囊提供了一个通过立体选择性蛋白质结合来调节生物相互作用的平台.
- 表面形态和性显著影响白蛋白吸附和细胞吸收.
- 这些发现为设计具有量身定制的药理动力学特征和增强药物递送功效的性纳米载体开辟了道路.
相关概念视频
Chirality in Nature
13.2K
Chirality is the most intriguing yet essential facet of nature, governing life’s biochemical processes and precision. It can be observed from a snail shell pattern in a macroscopic world to an amino acid, the minutest building block of life. Most of the snails around the world have right-coiled shells because of the intrinsic chirality in their genes. All the amino acids present in the human body exist in an enantiomerically pure state, except for glycine - the sole achiral amino acid.
13.2K
Drug Distribution: Plasma Protein Binding
5.5K
Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...
5.5K
Factors Affecting Protein-Drug Binding: Drug Interactions
117
Drug interactions are a critical aspect of pharmacology and can occur when two or more drugs compete for the same binding site. This competition can result in one drug displacing another, altering the effect of the displaced drug. Drug interactions are complex processes that rely heavily on how much of the displacer drug is present and how strongly it can bind to the same sites as the displaced drug.
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
117
Properties of Enantiomers and Optical Activity
16.8K
It is essential to understand the difference between chiral and achiral interactions and the implications thereof in optical activity and their applications. Just as our feet, which are chiral, interact uniquely with chiral objects, such as a pair of shoes, but identically with achiral socks, enantiomers of a molecule exhibit different properties only when they interact with other chiral media. An example of a significant implication from this facet is the phenomenon known as optical activity,...
16.8K
Chirality at Nitrogen, Phosphorus, and Sulfur
5.7K
Chirality is most prevalent in carbon-based tetrahedral compounds, but this important facet of molecular symmetry extends to sp3-hybridized nitrogen, phosphorus and sulfur centers, including trivalent molecules with lone pairs. Here, the lone pair behaves as a functional group in addition to the other three substituents to form an analogous tetrahedral center that can be chiral.
A consequence of chirality is the need for enantiomeric resolution. While this is theoretically possible for all...
A consequence of chirality is the need for enantiomeric resolution. While this is theoretically possible for all...
5.7K
Drug Binding to Blood Components
125
When drugs enter systemic circulation, they interact with various components of the blood, including proteins such as human serum albumin (HSA), α1-acid glycoprotein (AAG), lipoproteins, globulins, and red blood cells (RBCs).
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are...
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are...
125


